Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phylos

Phylos
2008 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$2M LATEST DEAL AMOUNT
5 INVESTORS
Description

Operator of an agricultural genomics company designed to enhance the next generation of hemp and cannabis. The company's services offer a suite of tools using modern molecular genetics and computational biology to provide breeding and research and development services to global partners, enabling cannabis growers and cultivators to understand the breadth of genetics in their catalog, evaluate development of additional varieties and drive business growth.

Website
Formerly Known As
Phylos Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 959 SouthEast Division Street
  • Suite 420
  • Portland, OR 97214
  • United States

+1 (503) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Phylos’s full profile, request a free trial.

Phylos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 10-May-2019 $2M 000.00 Completed Generating Revenue
6. Later Stage VC 15-Jan-2019 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Jun-2017 000 00.00 0000 Completed Generating Revenue
4. Accelerator/Incubator 00.00 Completed Generating Revenue
3. Angel (individual) 17-Jan-2014 000 00.00 00.00 Completed Generating Revenue
2. Angel (individual) 30-Mar-2011 $1000K $2.4M 000 Completed Startup
1. Angel (individual) 14-Nov-2008 $1.4M $1.4M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Phylos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 000,000 000.00 000.00 00 000.00 00.000
Series A1 000,000 000.00 000.00 00 000.00 00.000
Series A 71,517 $19.93 $19.93 1x $19.93 15.61%
To view this company’s complete Cap Table, request access »

Phylos Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arcadian Fund Venture Capital Minority 000 0000 000000 0
Big Rock Venture Capital Minority 000 0000 000000 0
Entourage Effect Capital PE/Buyout 000 0000 000000 0
Slow Ventures Venture Capital Minority 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator Minority 000 0000 000000 0

Phylos Executive Team (8)

Name Title Board
Seat
Contact
Info
Mowgli Holmes Ph.D Co-Founder, Chief Scientific Officer, Chief Executive Officer & Board Member
Scott Bowman Chief Financial Officer
Ralph Risch Chief Operating Officer
Nishan Karassik Co-Founder, Chief Innovation Officer & Board Member
Sarah Finne Executive
You’re viewing 5 of 8 executives. Get the full list »

Phylos Board Members (5)

Name Representing Role Since Contact
Info
Lada Rasochova Ph.D Self Board Member & Advisor 000 0000
Mowgli Holmes Ph.D Phylos Co-Founder, Chief Scientific Officer, Chief Executive Officer & Board Member 000 0000
Nishan Karassik Phylos Co-Founder, Chief Innovation Officer & Board Member 000 0000
Timothy Gregory Phylos Board Member & Advisor 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »